Alan Todd Roth
Known title: Senior Managing DirectorCIK: 0001662980
Associated companies
Transaction History
| REG | ▲ Buy | Option Exercise | 17,374 | — | 2/12/2026 | View on chart |
| REG | ▼ Sell | Tax Withholding | 6,846 | $502K | 2/12/2026 | View on chart |
| REG | ▼ Sell | Open Market | 8,000 | $616K | 2/10/2026 | View on chart |
| REG | ▼ Sell | Tax Withholding | 4,304 | $305K | 2/12/2025 | View on chart |
| REG | ▲ Buy | Option Exercise | 10,644 | — | 2/12/2025 | View on chart |
| REG | ▼ Sell | Open Market | 4,250 | $299K | 8/14/2024 | View on chart |
| REG | ▲ Buy | Option Exercise | 12,560 | — | 2/15/2024 | View on chart |
| REG | ▼ Sell | Tax Withholding | 5,146 | $326K | 2/15/2024 | View on chart |
| REG | ▼ Sell | Open Market | 3,869 | $250K | 12/5/2023 | View on chart |
| REG | ▲ Buy | Option Exercise | 11,333 | — | 2/7/2023 | View on chart |
| REG | ▼ Sell | Tax Withholding | 5,000 | $334K | 2/7/2023 | View on chart |
| REG | ▼ Sell | Open Market | 3,000 | $198K | 11/10/2022 | View on chart |
| REG | ▲ Buy | Option Exercise | 8,847 | — | 2/4/2022 | View on chart |
| REG | ▼ Sell | Tax Withholding | 4,178 | $299K | 2/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Regency Centers Faces Analyst Adjustments Amid Rate Concerns
Regency Centers is navigating a challenging environment as broader REITs face pressure from high interest rates. Recent analyst actions include Truist assuming coverage at a Buy rating and Barclays lowering its price target to $85 while maintaining an Overweight stance. The company is also preparing for its third-quarter 2026 earnings call, with the stock currently trading near its 52-week low.
Regency Centers Faces Analyst Adjustments Amid Rate Concerns. Regency Centers is navigating a challenging environment as broader REITs face pressure from high interest rates. Recent analyst actions include Truist assuming coverage at a Buy rating and Barclays lowering its price target to $85 while maintaining an Overweight stance. The company is also preparing for its third-quarter 2026 earnings call, with the stock currently trading near its 52-week low.